Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about GSK says it aims to bring FDA-approved antibody therapy to India for Covid on Business Standard. Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.
Subscription Notification We have noticed that there is an issue with your subscription billing details. Please update your billing details here Please update your billing information The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription. Your subscription will end shortly Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
Sir John Bell fears UK risks talent exodus after AstraZeneca boss suffers shareholder revolt over pay
GSK moves to make up ground in vaccine race Company is talking to governments about creating vaccine manufacturing facilities about 4 hours ago GlaxoSmithKline is banking that it can come back from behind in the race for a Covid-19 vaccine and play an important role preparing for new pandemics after releasing positive trial data. The vaccine maker is talking to governments including the UK about creating vaccine manufacturing facilities on their home turf, and is investing heavily in mRNA, the technology behind the successful shots from BioNTech/Pfizer and Moderna. GSK has not contribute...
GSK moves into the vaccine race GlaxoSmithKline says it can backtrack on the Covid-19 vaccine and play an important role in preparing new pandemics after testing positive data. The vaccine maker is talking to internal governments in the UK about creating vaccine manufacturing facilities in their homes, and is investing heavily in mRNA, behind the successful plans of BioNTech / Pfizer and Moderna. GSK has not helped last year to any generation of Covid-19 vaccines his French partner Sanofi it had to be repeated due to a dosing error. The company decided to provide an assistant that promotes t...